Trial intelligence / Profile preview

Oliceridine for outpatient cystoscopy sedation in elderly patients

ChiCTR2500100520Phase 4Not yet recruiting

Sponsor
The Second Hospital of Jilin University
Start
Apr 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of oliceridine in Micturition disorder (3 arms), sponsored by The Second Hospital of Jilin University. Primary endpoints: NRS score and Incidence of moderate to severe urinary tract irritation. Planned start Apr 2025; status: not yet recruiting.

02

Drugs

oliceridine
03

Conditions

Micturition disorder

Beyond the preview

Go deeper on ChiCTR2500100520.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500100520.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call